{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T17:03:09Z","timestamp":1649091789161},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,1,2]],"date-time":"2017-01-02T00:00:00Z","timestamp":1483315200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1007\/s12020-016-1222-0","type":"journal-article","created":{"date-parts":[[2017,1,2]],"date-time":"2017-01-02T03:36:41Z","timestamp":1483328201000},"page":"7-9","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Does parathyroid hormone control bone quality?"],"prefix":"10.1007","volume":"56","author":[{"given":"Dolores","family":"Shoback","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,1,2]]},"reference":[{"key":"1222_CR1","doi-asserted-by":"publisher","unstructured":"C. Cipriani, A. Abraham, B.C. Silva, N.E. Cusano, M.R. Rubin, D. J. McMahon, C. Zhang, D. Hans, S.J. Silverberg, J.P. Bilezikian. Skeletal changes after restoration of the euparathyroid state in patients with hypoparathyroidism and primary hyperparathyroidism. Endocrine (2016) doi:\n                        10.1007\/s12020-016-1101-8\n                        \n                     (pub online 18 October 2016)","DOI":"10.1007\/s12020-016-1101-8"},{"key":"1222_CR2","doi-asserted-by":"publisher","first-page":"3462","DOI":"10.1210\/jc.2007-1215","volume":"93","author":"MR Rubin","year":"2008","unstructured":"M.R. Rubin, J.P. Bilezikian, D.J. McMahon, T. Jacobs, E. Shane, E. Siris, J. Udesky, S.J. Silverberg, The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years. J. Clin. Endocrinol. Metab. 93, 3462\u20133470 (2008). doi:\n                        10.1210\/jc.2007-1215","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1222_CR3","doi-asserted-by":"publisher","first-page":"3561","DOI":"10.1210\/jc.2014-1413","volume":"99","author":"JP Bilezikian","year":"2014","unstructured":"J.P. Bilezikian, M.L. Brandi, R. Eastell, S.J. Silverberg, R. Udelsman, C. Marcocci, J.T. Potts Jr, Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J. Clin. Endocrinol. Metabol 99, 3561\u20133569 (2014). doi:\n                        10.1210\/jc.2014-1413","journal-title":"J. Clin. Endocrinol. Metabol"},{"key":"1222_CR4","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1210\/jc.2015-3909","volume":"101","author":"DM Shoback","year":"2016","unstructured":"D.M. Shoback, J.P. Bilezikian, A.G. Costa, D. Dempster, H. Dralle, A.A. Khan, M. Peacock, M. Raffaelli, B.C. Silva, R.V. Thakker, T. Vokes, R. Bouillon, Presentation of hypoparathyroidism: etiologies and clinical features. J. Clin. Endocrinol. Metab. 101, 2300\u20132312 (2016). doi:\n                        10.1210\/jc.2015-3909","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1222_CR5","doi-asserted-by":"publisher","unstructured":"B.C. Silva, M.R. Rubin, N.E. Cusano, J.P. Bilezikian, Bone imaging in hypoparathyroidism. Osteoporos. Int. (2016). doi:\n                        10.1007\/s00198-016-3750-0","DOI":"10.1007\/s00198-016-3750-0"},{"key":"1222_CR6","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1002\/jbmr.470","volume":"26","author":"T Sikjaer","year":"2011","unstructured":"T. Sikjaer, L. Rejnmark, L. Rolighed L, L. Heickendorff, L. Mosekilde, the Hypoparathyroid Study Group, The effect of adding PTH (1\u201384) to conventional treatment of hypoparathyroidism: a randomized placebo-controlled study. J. Bone Miner. Res. 26, 2358\u20132370 (2011). doi:\n                        10.1002\/jbmr.470","journal-title":"J. Bone Miner. Res"},{"key":"1222_CR7","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S2213-8587(13)70106-2","volume":"1","author":"M Mannstadt","year":"2014","unstructured":"M. Mannstadt, B.L. Clarke, T. Vokes, M.L. Brandi, L. Ranganath, W.D. Fraser, P.L. Lakatos, L. Bajnok, R. Garceau, L. Mosekilde, H. Lagast, D. Shoback, J.P. Bilezikian, Efficacy and safety of recombinant human parathyroid hormone (1\u201384) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised phase 3 study. Lancet Diabetes Endocrinol. 1, 275\u2013283 (2014). doi:\n                        10.1016\/S2213-8587(13)70106-2","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1222_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1472-6823-13-1","volume":"13","author":"ML Mendonca","year":"2013","unstructured":"M.L. Mendonca, F.A. Pereira, M.H. Nogueira-Barbosa, L.M. Monsignore, S.R. Teixeira, P.C. Watanabe, L.M. Maciel, F.J. de Paula, Increased vertebral morphometric fracture in patients with postsurgical hypoparathyroidism despite normal bone mineral density. BMC Endocr. Disord. 13, 1 (2013). doi:\n                        10.1186\/1472-6823-13-1","journal-title":"BMC Endocr. Disord."},{"key":"1222_CR9","doi-asserted-by":"publisher","unstructured":"H. Chawla, S. Saha, D. Kandaswamy, R, Sharma, V. Sreenivas, R. Goswami, Vertebral fractures and bone mineral density in patients with idiopathic hypoparathyroidism on long term follow-up. J. Clin. Endocrinol. Metab. (2016) doi:\n                        10.1210\/jc.2016-3292","DOI":"10.1210\/jc.2016-3292"},{"key":"1222_CR10","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1002\/jbmr.2273","volume":"29","author":"L Underbjerg","year":"2014","unstructured":"L. Underbjerg, T. Sikjaer, L. Mosekilde, L. Rejnmark, Postsurgical hypoparathyroidism\u2014risk of fractures, psychiatric diseases, cancer, cataract, and infections. J. Clin. Endocrinol. Metab. 29, 2504\u20132510 (2014). doi:\n                        10.1002\/jbmr.2273","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-016-1222-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-016-1222-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-016-1222-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,3,27]],"date-time":"2017-03-27T13:18:31Z","timestamp":1490620711000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-016-1222-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,2]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["1222"],"URL":"https:\/\/doi.org\/10.1007\/s12020-016-1222-0","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,2]]}}}